News/ News/ R&D Ocugen, Histogenics merge to form eye disease specialist Phil Taylor eye disease, Histogenics, Ocugen 0 Comment US biotechs Ocugen and Histogenics have announced plans to merge, creating a specialist in drugs and gene therapies Share X Ocugen, Histogenics merge to form eye disease specialist https://pharmaphorum.com/news/ocugen-histogenics-merge-to-form-eye-disease-specialist/
